Relevance of achieved levels of markers of systemic inflammation following treatment

Details for Australian Patent Application No. 2005294165 (hide)

Owner The Brigham and Womens's Hospital, Inc.

Inventors Ridker, Paul M.

Agent Davies Collison Cave

Pub. Number AU-B-2005294165

PCT Pub. Number WO2006/042192

Priority 60/616,467 06.10.04 US

Filing date 6 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 2 February 2012

International Classifications

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/042192 Priority application(s): WO2006/042192

2 February 2012 Application Accepted

  Published as AU-B-2005294165

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005294173-Promotion of cell migration and axon regeneration in the CNS

2005294162-Connector transfer tool for internal structure stabilization systems